Pluri (PLUR) Total Debt (2018 - 2025)
Pluri's (PLUR) quarterly Total Debt came in at $27.8 million in Q4 2025, up 16.74% year-over-year from $23.8 million in Q4 2024, and up 0.88% quarter-over-quarter from $27.5 million in Q3 2025.
Analysis
Pluri (PLUR) Total Debt (2018 - 2025) Analysis & Trends
Pluri (PLUR) has reported Total Debt for 6 consecutive years, with $27.8 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Total Debt rose 16.74% year-over-year to $27.8 million in Q4 2025; TTM through Dec 2025 was $27.8 million, a 16.74% increase from a year earlier, with the FY2025 full-year figure at $27.3 million, up 13.58% from the prior year.
- Total Debt was $27.8 million for Q4 2025 at Pluri, up from $27.5 million in the prior quarter.
- Over five years, Total Debt peaked at $27.8 million in Q4 2025 and troughed at $20.7 million in Q3 2022.
- A 5-year average of $24.1 million and a median of $23.8 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt dropped 11.61% in 2022 and increased 16.74% in 2025, its largest moves.
- Over 5 years, Total Debt stood at $23.2 million in 2021, then decreased by 2.09% to $22.7 million in 2022, then gained by 7.61% to $24.4 million in 2023, then dropped by 2.47% to $23.8 million in 2024, then advanced by 16.74% to $27.8 million in 2025.
- The last three Total Debt figures came in at $27.8 million (Q4 2025), $27.5 million (Q3 2025), and $27.3 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 586.20 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 156.40 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 50.15 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 112.43 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 93.88 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 847.62 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Pluri | 11.95 Mn | -536,034.04 | 86,000.00 | 27.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 27.78 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 27.29 Mn |
| Mar 31, 2025 | 24.95 Mn |
| Dec 31, 2024 | 23.80 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Mar 31, 2024 | 24.07 Mn |
| Dec 31, 2023 | 24.40 Mn |
| Sep 30, 2023 | 23.17 Mn |
| Jun 30, 2023 | 23.53 Mn |
| Mar 31, 2023 | 23.35 Mn |
| Dec 31, 2022 | 22.68 Mn |
| Sep 30, 2022 | 20.72 Mn |
| Jun 30, 2022 | 21.68 Mn |
| Mar 31, 2022 | 22.92 Mn |
| Dec 31, 2021 | 23.16 Mn |
| Sep 30, 2021 | 23.44 Mn |
| Jun 30, 2021 | 23.85 Mn |
| Jun 30, 2018 | 243,000.00 |